3D InSight™ NAFLD (MASLD) Model for Screening and Discovery
Understand the biology of fatty liver disease and screen for small molecules and biologicals - all in the same in vitro platform.
Leveraging InSphero's market-leading 3D InSight™ NASH (MASH) model, our NAFLD (recently renamed to MASLD - Metabolic Dysfunction-associated Steatotic Liver Disease) platform offers equivalent advantages for fatty liver disease research. Experience a high-quality, scalable, and human-relevant 3D in vitro disease model that generates precise insights and facilitates efficient research throughput. Rely on our expertise in creating primary-cell spheroid models and inducing specific disease phenotypes, enabling us to tailor solutions to your needs - faster and more efficiently than anyone else.
Why NAFLD Screening with InSphero?
Your Success is Our Mission
Schedule a consultation with our experts